Pedro Stanton

    Pedro Stanton is a renowned author in the world of financial literature, specializing in the stock exchange and investment strategies. Graduating with a Bachelor’s degree in Economics from the prestigious Polytechnic University, Pedro combines theoretical knowledge with real-world market expertise. His initial foray into the professional world was with the globally recognized Bridge Investment Group, where he served in their Strategies Division. During his tenure there, he honed his skills in portfolio management and global macro strategy, which influence his writing significantly. Pedro's financial analysis has consistently provided readers with valuable insights into the ever-evolving global market. Stanton is admired for his accuracy and ability to break down complex financial principles into comprehensible concepts for the average reader.

    Nasdaq’s Hidden Gems Soar! Discover the Stocks You Missed

    Nasdaq’s Hidden Gems Soar! Discover the Stocks You Missed

    While big names like Apple and Amazon cooled off at the end of this year, lesser-known Nasdaq stocks quietly reached new peaks. As these tech giants faded, savvy investors turned their attention to promising opportunities elsewhere. Ares Capital (Nasdaq: ARCC) stood out
    1. January 2025
    NVIDIA’s Fiscal Revelations. What Lies Ahead?

    NVIDIA’s Fiscal Revelations. What Lies Ahead?

    NVIDIA, a leader in graphics processing unit (GPU) manufacturing, has a fiscal calendar that draws significant attention from investors and tech enthusiasts alike. “When does NVIDIA release its earnings?” is a question echoing through the market corridors with heightened anticipation. In the
    26. December 2024
    Big Moves in Biotech! Neuphoria’s Bold Transformation Unveiled

    Big Moves in Biotech! Neuphoria’s Bold Transformation Unveiled

    In an exciting development shaking up the biotech landscape, Neuphoria Therapeutics Inc., a company at the forefront of neuropsychiatric disorder treatment, has successfully implemented a strategic relocation plan for Bionomics Limited. Now headquartered in the United States instead of Australia, Neuphoria emerges
    24. December 2024
    1 8 9 10 11 12 23

    Languages